|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
251,510,000 |
Market
Cap: |
136.50(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$414.13 - $547.8 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 17 |
Guru Rank Value : 22.1 |
Guru Occurances : 4 |
|
|
|
|
|
|
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
44,753 |
50,998 |
52,427 |
76,587 |
Total Sell Value |
$23,062,766 |
$26,097,504 |
$26,775,666 |
$37,860,892 |
Total People Sold |
4 |
6 |
7 |
8 |
Total Sell Transactions |
5 |
7 |
10 |
14 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Haytaian Peter D |
EVP & President, Commercial |
|
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,032 |
44,443 |
|
- |
|
Haytaian Peter D |
EVP & President, Commercial |
|
2021-03-01 |
4 |
D |
$311.48 |
$4,432,672 |
D/D |
(14,231) |
18,411 |
|
- |
|
Alter Jeffrey D. |
EVP, IngenioRx & Anthem Health |
|
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,649 |
5,395 |
|
- |
|
Mccarthy Gloria M |
EVP & Chief Administrative Off |
|
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,032 |
56,160 |
|
- |
|
Mccarthy Gloria M |
EVP & Chief Administrative Off |
|
2021-03-01 |
4 |
D |
$311.48 |
$3,728,727 |
D/D |
(11,971) |
30,128 |
|
- |
|
Gallina John E |
EVP & Chief Financial Officer |
|
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,232 |
54,803 |
|
- |
|
Gallina John E |
EVP & Chief Financial Officer |
|
2021-03-01 |
4 |
D |
$311.48 |
$3,311,967 |
D/D |
(10,633) |
28,571 |
|
- |
|
Schneider Ryan M. |
Director |
|
2021-02-04 |
4 |
B |
$296.03 |
$503,251 |
D/D |
1,700 |
2,921 |
2.39 |
29% |
|
Haytaian Peter D |
EVP & President, Commercial |
|
2020-12-15 |
4 |
AS |
$312.01 |
$1,822,972 |
D/D |
(5,833) |
32,642 |
|
20% |
|
Haytaian Peter D |
EVP & President, Commercial |
|
2020-12-15 |
4 |
OE |
$146.93 |
$857,043 |
D/D |
5,833 |
38,475 |
|
- |
|
Gallina John E |
EVP & Chief Financial Officer |
|
2020-12-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,589 |
39,204 |
|
- |
|
Todt Blair Williams |
EVP and Chief Legal Officer |
|
2020-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
797 |
797 |
|
- |
|
Boudreaux Gail |
President and CEO |
|
2020-12-01 |
4 |
D |
$313.90 |
$4,634,420 |
D/D |
(14,764) |
53,594 |
|
- |
|
Haytaian Peter D |
EVP & President, Commercial |
|
2020-11-16 |
4 |
AS |
$330.77 |
$1,946,456 |
D/D |
(5,834) |
32,642 |
|
11% |
|
Haytaian Peter D |
EVP & President, Commercial |
|
2020-11-16 |
4 |
OE |
$100.77 |
$214,905 |
D/D |
1,708 |
38,476 |
|
- |
|
Penczek Ronald W |
SVP, Chief Accounting Officer |
|
2020-11-09 |
4 |
S |
$330.75 |
$396,569 |
D/D |
(1,199) |
3,229 |
|
-9% |
|
Zielinski Thomas C |
EVP & General Counsel |
|
2020-11-03 |
4 |
S |
$292.07 |
$2,680,917 |
D/D |
(9,175) |
17,910 |
|
-17% |
|
Zielinski Thomas C |
EVP & General Counsel |
|
2020-11-03 |
4 |
OE |
$232.04 |
$439,252 |
D/D |
1,893 |
19,803 |
|
- |
|
Haytaian Peter D |
EVP & President, Commercial |
|
2020-10-15 |
4 |
AS |
$287.58 |
$1,703,238 |
D/D |
(5,834) |
36,768 |
|
2% |
|
Haytaian Peter D |
EVP & President, Commercial |
|
2020-10-15 |
4 |
OE |
$100.77 |
$470,294 |
D/D |
4,667 |
42,602 |
|
- |
|
Haytaian Peter D |
EVP & President, Commercial |
|
2020-10-09 |
4 |
AS |
$295.00 |
$344,265 |
D/D |
(1,167) |
37,935 |
|
-1% |
|
Haytaian Peter D |
EVP & President, Commercial |
|
2020-10-02 |
4 |
AS |
$280.00 |
$1,306,760 |
D/D |
(4,667) |
39,102 |
|
6% |
|
Haytaian Peter D |
EVP & President, Commercial |
|
2020-10-02 |
4 |
OE |
$89.44 |
$446,784 |
D/D |
4,667 |
43,769 |
|
- |
|
Alter Jeffrey D. |
EVP, IngenioRx & Anthem Health |
|
2020-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,746 |
2,746 |
|
- |
|
Patel Prakash R |
EVP & President, DBG |
|
2020-09-04 |
4 |
D |
$276.22 |
$32,594 |
D/D |
(118) |
12,073 |
|
- |
|
634 Records found
|
|
Page 8 of 26 |
|
|